These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31533187)
1. Neurological Complications of Leprosy. Lau KHV Semin Neurol; 2019 Aug; 39(4):462-471. PubMed ID: 31533187 [TBL] [Abstract][Full Text] [Related]
2. Elimination of leprosy in India: An analysis. Sengupta U Indian J Dermatol Venereol Leprol; 2018; 84(2):131-136. PubMed ID: 29451189 [TBL] [Abstract][Full Text] [Related]
3. Recent advances in the treatment of leprosy. Ishii N Dermatol Online J; 2003 Mar; 9(2):5. PubMed ID: 12639458 [TBL] [Abstract][Full Text] [Related]
4. Leprosy: a glossary. Virmond M; Grzybowski A; Virmond L Clin Dermatol; 2015; 33(1):8-18. PubMed ID: 25432806 [TBL] [Abstract][Full Text] [Related]
5. [Leprosy, a neurologic disease]. Coeytaux A; Truffert A; Mueller Y; Antille C; Jackson Y Rev Med Suisse; 2007 May; 3(110):1178, 1180-4. PubMed ID: 17564345 [TBL] [Abstract][Full Text] [Related]
6. How can adherence with multi-drug therapy in leprosy be improved? Williams MC Lepr Rev; 2005 Jun; 76(2):160-1. PubMed ID: 16038249 [No Abstract] [Full Text] [Related]
7. Leprosy: too complex a disease for a simple elimination paradigm. Lockwood DN; Suneetha S Bull World Health Organ; 2005 Mar; 83(3):230-5. PubMed ID: 15798849 [TBL] [Abstract][Full Text] [Related]
8. [Leprosy - An overview from a pediatric perspective]. Magdorf K; Haas WH; Harms D; Höger PH; Griese M; Rank M Klin Padiatr; 2001; 213(5):266-70. PubMed ID: 11582524 [TBL] [Abstract][Full Text] [Related]
10. An update on the diagnosis and treatment of leprosy. Moschella SL J Am Acad Dermatol; 2004 Sep; 51(3):417-26. PubMed ID: 15337986 [No Abstract] [Full Text] [Related]
11. Response to 'Elimination of leprosy in India: An analysis'. Kumar B Indian J Dermatol Venereol Leprol; 2018; 84(4):443-444. PubMed ID: 29893302 [No Abstract] [Full Text] [Related]
12. [Present leprosy situation in the world in 2006]. Ishii N; Nagaoka Y; Mori S; Suzuki K Nihon Hansenbyo Gakkai Zasshi; 2007 Feb; 76(1):19-28. PubMed ID: 17315748 [TBL] [Abstract][Full Text] [Related]
13. Multidrug therapy--the pathway for global leprosy elimination. al-Qubati Y; al-Kubati AS Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482 [TBL] [Abstract][Full Text] [Related]
14. Treatment of leprosy/Hansen's disease in the early 21st century. Worobec SM Dermatol Ther; 2009; 22(6):518-37. PubMed ID: 19889136 [TBL] [Abstract][Full Text] [Related]
15. Challenges beyond elimination in leprosy. Naaz F; Mohanty PS; Bansal AK; Kumar D; Gupta UD Int J Mycobacteriol; 2017; 6(3):222-228. PubMed ID: 28776519 [TBL] [Abstract][Full Text] [Related]
17. Leprosy in the UK. Bharucha T; Lockwood D Br J Hosp Med (Lond); 2016 Oct; 77(10):C154-C156. PubMed ID: 27723400 [No Abstract] [Full Text] [Related]
18. About reactivation of the anti-hansenian programs through early detection of patients and systematic multidrug therapy. Nebout M Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):653-5. PubMed ID: 1299718 [No Abstract] [Full Text] [Related]
19. Leprosy in China. Zhang L Nihon Hansenbyo Gakkai Zasshi; 2003 Aug; 72(3):209-15. PubMed ID: 14598630 [TBL] [Abstract][Full Text] [Related]
20. Country profile: leprosy in Brazil. Penna ML; Grossi MA; Penna GO Lepr Rev; 2013 Dec; 84(4):308-15. PubMed ID: 24745130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]